HSP90AB1 and acute lymphoblastic leukemia: We found that the sensitivity of ALL cell lines to NVP-BEP800 was dependent on their expression level of SRC rather than HSP90, and all cell lines expressed HSP90 but only the ones expressing SRC were sensitive to the drug.